Mark Heffernan

This profile gathers the share dealings of Mark Heffernan in Nexvet Biopharma plc. The record holds 6 filings, for trades running from 1 July 2016 to 31 July 2017.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 2 August 2017 came the latest disclosure, a transaction for €624k in Nexvet Biopharma plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.